
Airway Stent Market Report 2026
Global Outlook – By Anatomical Site (Tracheal Stents, Laryngeal Stents, Bronchial stents), By Product Type (Expandable Stents, Non-Expandable Stents), By Material Type (Metal, Silicone, Hybrid), By End-User (Hospitals, Clinics) – Market Size, Trends, Strategies, and Forecast to 2035
Airway Stent Market Overview
• Airway Stent market size has reached to $10.66 billion in 2025 • Expected to grow to $15.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: Rising Prevalence Of Lung Diseases Drives Growth In Airway Stent Market • Market Trend: Advancing Personalized Airway Care With First-in-Human Patient-Specific 3D-Printed Tracheal T-Tubes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Airway Stent Market?
An airway stent refers to a medical device used to keep the airways open, ensuring proper airflow in individuals with narrowed or obstructed airways due to conditions such as tumors, strictures, or other respiratory disorders. They are commonly used in the treatment of tracheal, bronchial, or laryngeal obstructions to improve breathing and overall lung function. The main types of airway stent include tracheal stents, laryngeal stents, and bronchial stents. Tracheal stents are medical devices designed to support and keep open the trachea, which is the windpipe that connects the throat to the lungs and treats conditions that cause the trachea to become narrowed or obstructed, such as tumors or strictures. The product types are categorized into expandable stents and non-expandable stents, with material types such as metal, silicon, and hybrid. The end users include hospitals, clinics, home healthcare, ambulatory surgical centers, laboratories, and research facilities.
What Is The Airway Stent Market Size and Share 2026?
The airway stent market size has grown strongly in recent years. It will grow from $10.66 billion in 2025 to $11.46 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing prevalence of tracheal and bronchial strictures, rising incidence of lung cancer and airway tumors, growth in hospital-based interventional pulmonology procedures, increasing availability of metal and silicone stent materials, expanding adoption of palliative respiratory obstruction management.What Is The Airway Stent Market Growth Forecast?
The airway stent market size is expected to see strong growth in the next few years. It will grow to $15.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to rising demand for minimally invasive respiratory interventions, increasing uptake of hybrid and biodegradable airway stents, growth in outpatient and ambulatory airway stenting procedures, expanding clinical awareness of airway stent therapy outcomes, increasing adoption of precision-fit and customized airway stents. Major trends in the forecast period include increasing adoption of minimally invasive airway stent placement procedures for respiratory obstruction management, rising demand for patient-specific and anatomically tailored stent designs, growing use of biocompatible and hybrid stent materials to improve durability and tolerance, increasing clinical usage of airway stents in oncology-related airway obstruction cases, expanding utilization of airway stents across hospitals, ambulatory centers, and specialized respiratory care settings.Global Airway Stent Market Segmentation
1) By Anatomical Site: Tracheal Stents, Laryngeal Stents, Bronchial stents 2) By Product Type: Expandable Stents, Non-Expandable Stents 3) By Material Type: Metal, Silicone, Hybrid 4) By End-User: Hospitals, Clinics Subsegments: 1) By Tracheal Stents: Silicone Tracheal Stents, Metallic Tracheal Stents, Hybrid Tracheal Stents 2) By Laryngeal Stents: Silicone Laryngeal Stents, Self-Expanding Laryngeal Stents, Biodegradable Laryngeal Stents 3) By Bronchial Stents: Metallic Bronchial Stents, Silicone Bronchial Stents, Covered Bronchial Stents, Self-Expanding Bronchial StentsWhat Is The Driver Of The Airway Stent Market?
The increasing prevalence of lung diseases and respiratory disorders is expected to propel the growth of the airway stent market going forward. Lung diseases and respiratory disorders refer to a broad range of conditions affecting the lungs and respiratory system, impairing breathing and overall lung function. The increasing prevalence of lung diseases and respiratory disorders is driven by factors such as rising pollution levels, smoking habits, exposure to environmental toxins, and the aging population. Additionally, lifestyle changes and genetic predispositions contribute to the growing incidence of these health conditions. Airway stents are used in the increasing prevalence of lung diseases and respiratory disorders to provide structural support to the airways, alleviate obstruction, and improve airflow in patients with conditions such as tracheal stenosis or bronchial tumors. For instance, in May 2024, according to the National Center for Health Statistics, a U.S.-based health statistics agency, the prevalence of current asthma among adults aged 18 and over has risen to 8.7% in 2022. Asthma episodes within the past 12 months have also increased to 3.7% in 2022.Therefore, the increasing prevalence of lung diseases and respiratory disorders will drive the growth of the airway stent industry.Key Players In The Global Airway Stent Market
Major companies operating in the airway stent market are Medtronic Plc, Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, Cook Medical, KARL STORZ SE & Co. KG, Merit Medical Systems, MICRO-TECH (Nanjing) Co. Ltd., Taewoong Medical Co. Ltd., Alvimedica Medical Technologies Inc, M.I. Tech Co. Ltd., Pnn Medical A/S, Endo-Flex GmbH, InSitu Technologies, QualiMed Innovative Medizinprodukte GmbH, Novatech SA, Boston Medical Products Inc., Meditek Systems Pvt. Ltd., AndraTec GmbH, Allium Medical Solutions Ltd., Medi-Globe GmbH, Bess medizintechnik GmbHGlobal Airway Stent Market Trends and Insights
Major companies operating in the airway stent market are focusing on technological advancements such as patient-specific 3D-printed silicone airway devices to improve fit, reduce complications and treat anatomies that standard stents cannot accommodate. A patient-specific 3D-printed T-tube is custom-designed from a patient’s CT data and manufactured in medical-grade silicone to match the unique airway geometry, reducing mucus plugging, granulation and vocal-cord interference associated with poorly fitting commercial tubes. For instance, in July 2024, University Hospitals, a US-based health system, implanted the first-in-human patient-specific 3D-printed tracheal T-tube under FDA compassionate-use approval in partnership with VisionAir Solutions, a US-based medical device company that specialises in patient-specific silicone airway stents. The custom T-tube was created from the patient’s CT scan, tailored to exact airway dimensions, and resulted in fewer complications, improved vocal function and longer intervals between replacements versus the previous commercial T-tube.What Are Latest Mergers And Acquisitions In The Airway Stent Market?
In August 2023, Theken Companies, a US-based medical device manufacturer specializing in innovative orthopedic and spinal solutions, acquired VisionAir Solutions from Cleveland Clinic for an undisclosed amount. This acquisition is intended to enhance Theken Companies' portfolio of advanced airway management technologies, expand its market presence in the medical device sector, stimulate growth through an expanded product range, and elevate patient outcomes in airway management. VisionAir Solutions is a US-based provider of advanced airway management technologies.Regional Outlook
North America was the largest region in the airway stent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Airway Stent Market?
The airway stent market consists of sales of Y-shaped stents, biodegradable stents, and uncovered stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Airway Stent Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $11.46 billion |
| Revenue Forecast In 2035 | $15.27 billion |
| Growth Rate | CAGR of 7.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Anatomical Site, Product Type, Material Type, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Medtronic Plc, Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, Cook Medical, KARL STORZ SE & Co. KG, Merit Medical Systems, MICRO-TECH (Nanjing) Co. Ltd., Taewoong Medical Co. Ltd., Alvimedica Medical Technologies Inc, M.I. Tech Co. Ltd., Pnn Medical A/S, Endo-Flex GmbH, InSitu Technologies, QualiMed Innovative Medizinprodukte GmbH, Novatech SA, Boston Medical Products Inc., Meditek Systems Pvt. Ltd., AndraTec GmbH, Allium Medical Solutions Ltd., Medi-Globe GmbH, Bess medizintechnik GmbH |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
